Masahiro Sakai

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Venues

Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Sakai, Koichi Hayashi, Tomoyuki Ito, Haruka Otani, Yuya Mori, Shinsuke Ito, Keita Endo, Hiroto Matsuda, Kaede Yoshino, Koichi Kitamura, Eiji Kubota, Yasuaki Motomura, Yasuhiro Suzuki, Shigeki Fujitani, Toshihiko Suzuki
Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study. Medicine 102 (16) (2023)
Masahiro Sakai, Koichi Hayashi, Tomoyuki Ito, Haruka Otani, Yuya Mori, Shinsuke Ito, Keita Endo, Hiroto Matsuda, Kaede Yoshino, Koichi Kitamura, Eiji Kubota, Yasuaki Motomura, Yasuhiro Suzuki, Shigeki Fujitani, Toshihiko Suzuki
Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study. Medicine 102 (16) (2023)
Masahiro Sakai, Koichi Hayashi, Tomoyuki Ito, Haruka Otani, Yuya Mori, Shinsuke Ito, Keita Endo, Hiroto Matsuda, Kaede Yoshino, Koichi Kitamura, Eiji Kubota, Yasuaki Motomura, Yasuhiro Suzuki, Shigeki Fujitani, Toshihiko Suzuki
Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study. Medicine 102 (16) (2023)
Masahiro Sakai, Koichi Hayashi, Tomoyuki Ito, Haruka Otani, Yuya Mori, Shinsuke Ito, Keita Endo, Hiroto Matsuda, Kaede Yoshino, Koichi Kitamura, Eiji Kubota, Yasuaki Motomura, Yasuhiro Suzuki, Shigeki Fujitani, Toshihiko Suzuki
Sustained effect of leukocytapheresis/granulocytapheresis versus anti-human TNF-α monoclonal antibody on ulcerative colitis: A 2-year retrospective study. Medicine 102 (16) (2023)

Masahiro Sakai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masahiro Sakai